News
A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...
The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...
In the first of a series, columnist Joe MacDonald reflects on the birth of his oldest son, who hadn't yet been diagnosed with hemophilia.
A caregiver needs respite from the duties of watching over a chronically ill patient, columnist Cazandra Campos-MacDonald writes.
Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...
Successful immune tolerance induction (ITI) in hemophilia A patients with inhibitors led to lower treatment costs, a study ...
Columnist Alliah Czarielle says her husband, Jared, adapts to whatever hemophilia and epilepsy throw his way. Being present is the core.
Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.
Speak up, trust your intuition, and never be afraid to ask questions.
Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results